WallStSmart

PetMed Express Inc (PETS)vsRidgetech, Inc. (RDGT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PetMed Express Inc generates 28% more annual revenue ($168.86M vs $132.16M). RDGT leads profitability with a -0.9% profit margin vs -17.3%. PETS earns a higher WallStSmart Score of 43/100 (D).

PETS

Hold

43

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.3Quality: 5.0
Piotroski: 2/9Altman Z: 1.29

RDGT

Hold

39

out of 100

Grade: F

Growth: 4.7Profit: 4.0Value: 6.7Quality: 8.0
Piotroski: 4/9Altman Z: 2.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PETSUndervalued (+70.8%)

Margin of Safety

+70.8%

Fair Value

$10.16

Current Price

$1.65

$8.51 discount

UndervaluedFair: $10.16Overvalued
RDGTUndervalued (+82.8%)

Margin of Safety

+82.8%

Fair Value

$10.36

Current Price

$0.83

$9.53 discount

UndervaluedFair: $10.36Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PETS3 strengths · Avg: 9.3/10
EPS GrowthGrowth
266.7%10/10

Earnings expanding 266.7% YoY

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

RDGT4 strengths · Avg: 9.5/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Return on EquityProfitability
30.2%10/10

Every $100 of equity generates 30 in profit

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.4%8/10

Revenue surging 21.4% year-over-year

Areas to Watch

PETS4 concerns · Avg: 3.0/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

Market CapQuality
$39.24M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-100.6%2/10

ROE of -100.6% — below average capital efficiency

RDGT4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$3.39M3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-6.74M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-0.9%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : PETS

The strongest argument for PETS centers on EPS Growth, Debt/Equity, Price/Book.

Bull Case : RDGT

The strongest argument for RDGT centers on Price/Book, Return on Equity, Debt/Equity. Revenue growth of 21.4% demonstrates continued momentum.

Bear Case : PETS

The primary concerns for PETS are PEG Ratio, Market Cap, Piotroski F-Score.

Bear Case : RDGT

The primary concerns for RDGT are EPS Growth, Market Cap, Free Cash Flow.

Key Dynamics to Monitor

PETS profiles as a turnaround stock while RDGT is a growth play — different risk/reward profiles.

PETS carries more volatility with a beta of 0.79 — expect wider price swings.

RDGT is growing revenue faster at 21.4% — sustainability is the question.

RDGT generates stronger free cash flow (-7M), providing more financial flexibility.

Bottom Line

PETS scores higher overall (43/100 vs 39/100). RDGT offers better value entry with a 82.8% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

PetMed Express Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

PetMed Express, Inc., doing business as 1-800-PetMeds, is a pet pharmacy in the United States. The company is headquartered in Delray Beach, Florida.

Ridgetech, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?